Fulminant Hepatic Failure Bridged to Liver Transplantation with a Molecular Adsorbent Recirculating System: A Single-Center Experience

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Digestive Diseases and Sciences

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10620-006-3115-1PMID 16416211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver transplantation for fulminant hepatic failure

  2008cited by this paper
• Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system

  2004cited by this paper
• Noncardiogenic pulmonary edema induced by a molecular adsorbent recirculating system: case report

  2003cited by this paper
• Changes in Serum Electrolytes during Treatment of Patients in Liver Failure with Molecular Adsorbent Recirculating System

  2003cited by this paper
• Effect of molecular adsorbent recirculating system in hepatitis C virus‐related intractable pruritus

  2003cited by this paper
• Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry.

  2002cited by this paper
• Preparation of graphitic carbon nanofibers with the use of water-soluble supports.

  2002cited by this paper
• Bio-artificial liver support for acute liver failure: should we be using it to treat patients?

  2002cited by this paper
• Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure

  2001cited by this paper
• Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute‐on‐chronic liver failure

  2001cited by this paper
• NADPH diaphorase is developmentally regulated in rat olfactory epithelium

  2001cited by this paper
• Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure

  2001cited by this paper
• Peri-operative blood lactate levels in recipients of living-related liver transplantation.

  2000cited by this paper
• Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial

  2000cited by this paper
• Clinical experience with artificial liver support systems.

  2000cited by this paper
• New artificial liver support system (plasma perfusion detoxification) for hepatic coma. 1978.

  2000cited by this paper
• Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances.

  1999cited by this paper
• Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support.

  1999cited by this paper
• Cellular component of bioartificial liver support systems.

  1999cited by this paper
• What should we expect from a bioartificial liver in fulminant hepatic failure?

  1998cited by this paper
• Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure.

  1998cited by this paper
• Lactate blood levels in the perioperative period of orthotopic liver transplantation

  1997cited by this paper
• Fulminant hepatic failure: Summary of a workshop

  1995cited by this paper
• Acute liver failure.

  1993cited by this paper
• Acute liver failure: redefining the syndromes.

  1993influential reference
• A new procedure for the removal of protein bound drugs and toxins.

  1993cited by this paper
• Classification of acute liver failure

  1993cited by this paper
• Transjugular liver biopsy

  1992cited by this paper
• Early indicators of prognosis in fulminant hepatic failure.

  1989cited by this paper
• Regulation of lactate metabolism in vivo.

  1989cited by this paper
• Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

  1988cited by this paper
• Liver Transplantation for Fulminant Hepatic Failure

  1985cited by this paper
• Metabolism during hepatic transplantation: indicators of allograft function.

  1984cited by this paper
• Lactate homeostasis and lactic acidosis.

  1980cited by this paper
• Transjugular liver biopsy.

  1977cited by this paper

• Supports hépatiques artificiels : concepts et perspectives

  2019cites this paper
• Bio-artificial liver: An advanced therapy for liver failure

  2016cites this paper
• Artificial Liver Treatment, When and Which One?

  2016cites this paper
• Artificial liver support: a real step forward.

  2015cites this paper
• Ex Vivo Resection of Hepatic Neoplasia and Autotransplantation: A Case Report and Review of the Literature

  2015cites this paper
• Aus der Universitätsklinik für Neurochirurgie Tübingen

  2012cites this paper
• Utilisation de la dialyse MARS en toxicologie

  2012cites this paper
• MARS albumin dialysis in toxicology

  2012cites this paper
• Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure

  2011cites this paper
• Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS).

  2011cites this paper
• Pre-Operative Risk Factors Predict Post-Operative Respiratory Failure after Liver Transplantation

  2011cites this paper
• Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure.

  2010cites this paper
• A new prognostic formula for adult acute liver failure using computer tomography-derived hepatic volumetric analysis

  2009influential citation
• Albumin Dialysis MARS: Knowledge from 10 Years of Clinical Investigation

  2009cites this paper
• Acetaminophen hepatotoxicity and acute liver failure.

  2009cites this paper
• The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients *

  2008cites this paper
• Therapeutic Efficacy of the Latest Extracorporeal Elimination Procedure (Prometheus® Treatment) in Acute Hepatic Failure due to Intoxication

  2008cites this paper
• MARS®: a futile tool in centres without active liver transplant support

  2007cites this paper
• Albumin dialysis: an update

  2007cites this paper
• Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system.

  2007cites this paper
• MARS dialysis in decompensated alcoholic liver disease: A single‐center experience

  2007cites this paper
• Epidemiology of acute liver failure

  2007cites this paper
• [Therapeutic effect of the latest extracorporal elimination procedure (Prometheus treatment) in acute liver failure caused by intoxication].

  2007cites this paper
• Artificial and Bioartificial Liver Support

  2007cites this paper
• The therapeutical efficiency of the newest extracorporal elimination procedure (Prometheus® treatment) in acute liver failure caused by intoxication

  2007cites this paper
• A molecular adsorbent recycling system in treating posthepatectomy acute hepatic failure patients with hepatocellular carcinoma: a bridge to liver transplantation

  2006cites this paper
• Current World Literature

  2006cites this paper
• Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.

  2006cites this paper
• Liver transplantation of a HELLP syndrome donor liver in acute fulminant hepatitis B with deltavirus coinfection

  2006cites this paper